Press Releases
Benzinga Professional
- 10:38 AM UPDATE: Morgan Stanley Maintains Overweight on Monster Beverage Despite Recent Sales Slowdown
- 10:32 AM Benzinga's Volume Movers
- 10:25 AM AllThingsD Reporting AOL Has Considered 'Bling Thing,' 'a New Subscription Commerce Business'
- 10:23 AM Stocks Hitting 52-Week Lows
- 10:23 AM JP Morgan Maintains Overweight on Boeing Company (The), Raises PT to $105.00
- 10:23 AM Maxim Group Maintains Buy on Qihoo 360 Technology Co. Ltd., Raises PT to $48.00
- 10:22 AM Stocks Hitting 52-Week Highs
- 10:22 AM Goldman Sachs Downgrades Neustar, Inc. to Neutral
- 10:22 AM Goldman Sachs Downgrades Equifax, Inc. to Neutral
- 10:22 AM Goldman Sachs Upgrades WNS (Holdings) Limited to Buy, Raises to $19.00
- 10:21 AM Goldman Sachs Upgrades Accenture plc. to Buy, Raises to $90.00
- 10:20 AM Piper Jaffray Maintains Neutral on Hibbett Sports, Inc., Raises PT to $62.00
- 10:20 AM Piper Jaffray Maintains Overweight on Monsanto Company, Raises PT to $135.00
- 10:20 AM US Dollar Has First Down Day Since May 8; Christopher Vecchio, Currency Analyst at DailyFX, comments on the US Dollar and the Japanese Yen
- 10:19 AM Piper Jaffray Maintains Overweight on American Vanguard Corporation, Raises PT to $37.00
Brain Trust
MORE FROM InvestorsObserver
MORE FROM Michael Prus
- "Top 10" Winners (and losers) of US Mobile e-Retail
- Stocks Hitting 52-Week Lows
- Stocks Hitting 52-Week Highs
- US Dollar Has First Down Day Since May 8; Christopher Vecchio, Currency Analyst at DailyFX, comments on the US Dollar and the Japanese Yen
- UPDATE: BTIG Research Initiates Voya Financial with Buy on Compelling Value Play
- UPDATE: Morgan Stanley Upgrades Dangdang to Overweight on Improving Margins
- UPDATE: Canaccord Genuity Initiates Michael Kors with Buy on Multiple Positive Factors
- Morning Market Losers
- UPDATE: Bank of America Initiates Franklin Street Properties with Neutral on Fair Valuation
- UPDATE: J.P. Morgan Initiates M/I Homes with Overweight on Near Industry-Leading Order Growth, Inexpensive Valuation
- The 5 Can't-Miss Apple Stories from the Past Week
- Earnings Expectations for the Week of May 20
- U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying
- Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer
- Barron's Recap: Cues from Cooperman
- Benzinga's M&A Chatter for Friday May 17, 2013
- Campbell Soup Earnings Preview: Double-Digit Revenue Growth Expected
- Can You Think of 9 Companies with Stellar Customer Service?
- Presidential Visit Puts Myanmar Investment Theme in Spotlight
- Benzinga Market Primer: Monday, May 20